Aberdeen Group
SPTX

Aberdeen Group’s Seaport Therapeutics SPTX Stock Holding History

Aberdeen Group’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Buy
+310,355
New +$5.46M 0.01% 657

Other funds holding SPTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Aberdeen Group's SPTX Position: Q2 2026 in Review

Aberdeen Group opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 310,355 shares worth $6.74M. The stake represents 0.01% of the portfolio and ranks #657 among its holdings.

5 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

  • Aberdeen Group held 310,355 shares of Seaport Therapeutics worth $6.74M as of Q2 2026.
  • Seaport Therapeutics was a new Aberdeen Group position in Q2 2026.
  • Seaport Therapeutics made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #657 holding.
  • 5 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.